EU Commission approves Kimberly-Clark's (KMB) acquisition of Kenvue (KVUE), subject to conditions

Conditional EU clearance of this size is the standard template in consumer staples combinations: a phase one or phase two review resolved with divestiture undertakings in overlapping categories, typically specific brands or geographies rather than structural opposition to the deal itself. The pattern in comparable household and personal care tie-ups has been that Brussels extracts remedies around the most concentrated product lines while approving the wider transaction, so the operative detail is the scope of the conditions rather than the approval headline. Watch for which assets are carved out, since disposal packages in past episodes have drawn competing bidders and occasionally produced read-across for peer valuations in the affected categories. Remaining gatekeepers are the other major jurisdictions, with the US process historically the more consequential hurdle for a domestic pairing of this kind, plus any shareholder or financing milestones still outstanding. Deal spread behaviour in prior conditional clearances has been to compress on the decision and then re-widen only if remedy terms prove heavier than expected. Integration risk, not antitrust, has tended to be the dominant driver of combined-company performance in past staples megadeals.